[144] Vicarious Surgical Inc. SEC Filing

Rhea-AI Filing Summary

Vicarious Surgical Inc. (RBOT) filing is a Form 144 notice reporting proposed sales of Class A common stock by an insider. The filing lists a planned sale of 653 shares through UBS Financial Services with an aggregate market value of $4,166.14 and an approximate sale date of 08/20/2025 on the NYSE. The securities were acquired on 08/19/2025 by restricted stock lapse, showing 1,902 shares acquired in that transaction. The filer also disclosed three prior sales in the past three months totaling 1,115 shares with gross proceeds of $8,039 on 05/20/2025, 06/03/2025, and 06/23/2025. The notice includes the standard representation that the seller is not aware of undisclosed material adverse information.

Insights

Securities Analyst

TL;DR: Routine insider notice of small proposed sale following restricted stock lapse; transaction size appears immaterial to shareholders.

The Form 144 documents a proposed sale of 653 Class A shares valued at $4,166.14 to be executed through UBS on the NYSE after a restricted stock lapse dated 08/19/2025. Recent sales in May and June totaled 1,115 shares for $8,039, indicating ongoing disposition of small holdings rather than a single large liquidation. For investors, these filings are compliance disclosures and do not, by themselves, provide evidence of material company-level events.

Corporate Governance Expert

TL;DR: Compliance-focused disclosure showing insider adherence to Rule 144 procedures following restriction lapse.

The notice includes required information about acquisition method (restricted stock lapse) and aggregation of prior sales within three months, meeting Rule 144 reporting obligations. The representation that no undisclosed material adverse information is known is included. From a governance perspective, this appears procedural and consistent with expected insider reporting post-vesting.

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Class A Common Stock	UBS Financial Services Inc 1000 Harbor Blvd 3rd Floor Weehawken NJ 07086	653	4166.14	5298253	08/20/2025	NYSE

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Class A Common Stock	08/19/2025	Restricted Stock Lapse	Vicarious Surgical Inc.			1902	08/19/2025	Restricted Stock Lapse

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
Sammy Khalifa 78 4th Ave Waltham MA 02451	Class A Common Stock	05/20/2025	653	4748
Sammy Khalifa 78 4th Ave Waltham MA 02451	Class A Common Stock	06/03/2025	239	1641
Sammy Khalifa 78 4th Ave Waltham MA 02451	Class A Common Stock	06/23/2025	223	1650

144: Remarks and Signature

Remarks

Date of Notice

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

FAQ

What securities are being sold in the Form 144 for RBOT?

The filing reports proposed sale of Class A Common Stock, specifically 653 shares to be sold through UBS Financial Services.

When is the approximate sale date reported in the Form 144?

The approximate date of sale listed is 08/20/2025.

How were the shares being sold acquired according to the filing?

The securities were acquired on 08/19/2025 via a restricted stock lapse from Vicarious Surgical Inc.

What recent sales by the same person are disclosed in the filing?

The filer disclosed three sales in the past three months: 05/20/2025 (653 shares), 06/03/2025 (239 shares), and 06/23/2025 (223 shares), totaling 1,115 shares and gross proceeds of $8,039.

What is the aggregate market value of the proposed sale?

The aggregate market value for the 653 shares is reported as $4,166.14.